Rethinking Clinical Trials

OCTOBER 18, 2023

The World Health Organization defines social determinants of health as non-medical factors that influence health outcomes and conditions in which people are born, grow, work, live, and age, and the wider set of forces and systems shaping the conditions of daily life. Insurance status is captured in an encounter level with the payor name.

Clinical Trials 118

Clinical Trials Clinical Trials Clinical Research Research 118

pharmaphorum

APRIL 14, 2022

million price tag. million if paid through an outcomes-based contract for patients with sustained transfusion independence.” US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its proposed $2.1

Gene Therapy 64

Gene Therapy Gene Marketing Clinical Trials 64

Rethinking Clinical Trials

DECEMBER 6, 2022

It was a labor of love; the site payment was low; we asked friends to be sites in the trial. This trial turned out to be more challenging than anticipated. It’s almost always harder in my experience. Sites have a lot of trials that are competing. One pays more than another. We did what we could to make the entry criteria as easy as possible.

Trials 130

Trials Clinical Trials Clinical Trials Compliance 130

XTalks

JUNE 28, 2023

million price tag of Elevidys, a one-time gene therapy. Instead of a treatment outcome-based payment approach that has been adopted by other gene therapies to help with costs, Sarepta is working on “some innovative concepts” with payers, he said. In a media call, Sarepta CEO Douglas Ingram revealed the $3.2

Gene Therapy 98

Gene Therapy Gene Protein FDA Approval 98

XTalks

SEPTEMBER 27, 2022

The record-breaking price tag of Skysona is not surprising for one-time gene therapies like it. The price tag reflects “the clinical benefit [it] provides as an urgently needed treatment option to slow the progression of neurologic dysfunction in children impacted by progressive, irreversible and fatal rare disease,” Obenshain added.

FDA Approval 52

FDA Approval Gene Therapy Drugs Gene 52

The Pharma Data

MAY 4, 2021

The board decided to maintain Pfizer’s quarterly dividend at its current level despite the planned declaration of a dividend payment by Viatris that would be payable to those Pfizer shareholders that have elected to continue holding Viatris shares received from the combination of Upjohn and Mylan (4). second-quarter 2021 dividend.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharma Marketing Network

JUNE 8, 2020

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.

HR 40

HR Marketing Doctors Doctor 40